A Study of Monepantel in Individuals With Motor Neurone Disease

Clinical trial NCT04894240 · COMPLETED

Trial details

NCT number: NCT04894240
Sponsor: Neurizon Therapeutics Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Motor Neuron Disease

Start date: 2022-06-28
Primary completion: 2023-11-29
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.